AbbVie · 3 days ago
Director, U.S Policy, Government Affairs
AbbVie is a company focused on discovering and delivering innovative medicines and solutions for serious health issues. The Director, U.S. Policy will lead efforts in monitoring and analyzing key federal public policy issues impacting AbbVie, particularly in commercial insurance and PBM reform, while developing strategies and communications to support the organization’s objectives.
BiotechnologyFinancial ServicesHealth CareMedicalPharmaceuticalVenture Capital
Responsibilities
Identify, track, and analyze commercial insurance and PBM reform legislative and regulatory developments that impact AbbVie and its products
Work with internal stakeholders to determine how federal legislative and regulatory developments related to commercial insurance and PBM reform impact AbbVie and the patients we serve
Develop clear and effective communications to ensure that internal AbbVie stakeholders are aware of and understand key issues and developments at the federal level
Provide internal expertise on federal policy and develop policy materials such as talking points, policy papers, and legislative/amendment language, in collaboration with legal, to support Federal Government Affairs, Legal and BESD colleagues in driving adoption of AbbVie priorities and policy positions
Develop novel policy ideas/options in collaboration with internal AbbVie stakeholders and ensure that positions are aligned with key business objectives, in collaboration with the key partners
Create persuasive materials and compelling messages for the Federal Government Affairs team to utilize in their communications with policymakers and third-party stakeholders
Work closely with the GA Therapeutic Area Strategies team and above brand internal colleagues to understand brand strategies and incorporate key insights into policy analyses and development
Develop, direct, and manage external analysis, projects, and other initiatives supported by external consultants
Ensure alignment with International Policy functions to ensure global consistency of AbbVie’s public policy positions
Represent AbbVie in external policy discussions, as needed, to position AbbVie as an industry thought leader
Lead discussion with senior leaders at AbbVie to garner cross functional support for our initiatives including leaders in Federal Government Affairs, BESD, Global Policy and U.S. Access Strategies, Public Affairs, Legal and Market Access
Qualification
Required
Minimum ten years of experience in progressively more responsible roles
Must possess significant experience in commercial insurance & PBM policy, including deep ERISA and ACA technical understanding with knowledge of government affairs, public policy, market access and/or the law
Ability to identify policy opportunities and challenges, to connect policy to commercial business impact, and to develop concise and persuasive public policy positions and other written materials within the context of the political environment
Exceptional communicator (verbal, written, presentations). Ability to effectively communicate public policy information and positions to internal and external stakeholders
Must be able to work collaboratively with multiple cross-functional peers, handle ambiguity well, and enjoy working in a collegial, yet fast-paced and high performing environment
Strong analytical, critical thinking, and organizational skills; strong attention to detail
Bachelor's degree in related field such as public policy, health care administration, or political science required
Some domestic travel (15 percent) required
Preferred
Relevant experience in health care with a focus on pharmaceuticals policy preferred
Advance degree preferred (MPH, MBA, JD, MPP, PhD)
Benefits
Paid time off (vacation, holidays, sick)
Medical/dental/vision insurance
401(k)
Short-term incentive programs
Long-term incentive programs
Company
AbbVie
AbbVie is a biopharmaceutical company focused on immunology, oncology, neuroscience, virology, and aesthetics. It is a sub-organization of AbbVie.
Funding
Current Stage
Public CompanyTotal Funding
$15B2024-02-27Post Ipo Debt· $15B
2023-03-08Post Ipo Equity· $0.25M
2012-12-20IPO
Leadership Team
Recent News
2026-01-18
2026-01-17
Company data provided by crunchbase